HTG Establishes a French Subsidiary to Support Expanding Growth 

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the formation of a French subsidiary, HTG Molecular Diagnostics France SARL (“HTG France”) in November 2018. This entity is expected to further facilitate HTG’s ability to generate European product revenue and to improve its responsiveness to the needs of its growing customer base in Europe. In conjunction with the subsidiary formation, HTG has also created an application incubator laboratory in Sausheim, France, which is expected to accelerate additional product applications and to provide direct customer service to European accounts.Continue reading

National Academy of Inventors Welcomes Two UA Professors as Fellows

Two distinguished University of Arizona professors and innovators have been named as Fellows of the National Academy of Inventors (NAI). 

Dr. Thomas Koch, professor and dean of the College of Optical Sciences, and Dr. Harrison Barrett, Regents’ Professor of Medical ImagingOptical Sciences and Applied Mathematics, will now join a growing cadre of distinguished Fellows from the UA.Continue reading

Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

  • Roche collaborates with Merck to develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR)
  • Roche will seek FDA approval for biomarker panel expected to provide a standardized predictive testing option for dMMR

Continue reading

Arizona Bioindustry Association receives grant from the U.S. Economic Development Administration to Support Building an Evergreen Seed Fund for Arizona-based Health Innovations

CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that it has been awarded a $299,750 grant  from the U.S. Economic Development Administration’s (EDA) 2018 Regional Innovation Strategies (RIS) program competition to support the creation of a sustainable seed fund for life science innovation in Arizona.  In addition to the federal contribution to the project, AZBio and its partners will provide matching support in excess of $500,000 over the three-year term of the project.  These resources support the seed fund capital campaign, structure and operations as well as programs designed to help Arizona life science companies prepare for the investment process.  Neither the federal funds or the matching funds may be used to capitalize the fund itself or for direct investment into individual companies.Continue reading